
Opinion|Videos|September 23, 2024
Treatment Options to Manage and Prevent Relapses in NMOSD
Author(s)Jacqueline Nicholas, MD, MPH
Jacqueline Nicholas, MD, MPH, discusses available treatment options for NMOSD, including management of acute phases, relapses, and symptom control, as well as how both traditional and newer therapies address different aspects of NMOSD pathophysiology.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What treatment options are available for NMOSD (Kümpfel 2024)?
- Discuss options available for treatment of the acute phase and relapses and prevention of relapses.
- Discuss the management of symptoms.
- How do the traditional and newer treatments target various aspects of NMOSD pathophysiology?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
Using Human iPSC Models to Dissect PIRA Mechanisms in Progressive Multiple Sclerosis: Valentina Fossati, PhD
5








